About Suma Genomics
Suma Genomics is a company based in Manipal (India) founded in 2019. Suma Genomics offers products and services including Next Generation Sequencing, Sanger Sequencing, MLPA/TP-PCR, and Prenatal Diagnosis. Suma Genomics operates in a competitive market with competitors including Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
- Headquarter Manipal, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Suma Genomics Private Limited
- Date of Incorporation 04 Jan, 2019
- Jurisdiction Manipal, Karnataka, India
-
Annual Revenue
$115.07 K (USD)138.78as on Mar 31, 2022
-
Net Profit
$5.9 K (USD)17454.86as on Mar 31, 2022
-
EBITDA
$15.64 K (USD)218.14as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Suma Genomics
Suma Genomics offers a comprehensive portfolio of products and services, including Next Generation Sequencing, Sanger Sequencing, MLPA/TP-PCR, and Prenatal Diagnosis.
Massively parallel technology for ultra-high throughput DNA analysis.
Method to detect point mutations in specific genes.
Technique using probes for targeted genomic region detection.
Service for diagnosing genetic conditions in fetuses.
Funding Insights of Suma Genomics
Detailed funding history for Suma Genomics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Suma Genomics
Investment portfolio details for Suma Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Suma Genomics
Detailed financials for Suma Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Suma Genomics Comparisons
Peer comparison for Suma Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Suma Genomics
Suma Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Macrogen, Genewiz, BGI, Transnetyx and Acclinate, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Next-generation sequencing and genomics services are provided globally.
|
|
| Locked | Locked | Locked |
Genomic services are provided for the life sciences industry.
|
|
| Locked | Locked | Locked |
BGI is engaged in genomics and precision medicine solutions.
|
|
| Locked | Locked | Locked |
Automated genotyping services for murine cell lines are developed.
|
|
| Locked | Locked | Locked |
Clinical trial services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Molecular analysis services for research and drug development are offered.
|
Detailed competitors of Suma Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Suma Genomics
Complete news archive for Suma Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suma Genomics
Suma Genomics was founded in 2019.
Suma Genomics is headquartered in Manipal, India. It is registered at Manipal, Karnataka, India.
Annual revenue of Suma Genomics is $115.07K as on Mar 31, 2022.
Suma Genomics was founded in 2019 in Manipal, India, within the genomics sector. Sequencing data is utilized by the company to analyze mutations linked to diseases. Bioinformatics and genetic testing technologies are employed in these operations. Services focus on identifying genetic disorders through precise detection methods. The company operates primarily from its base in India, serving needs in genetic analysis.
Suma Genomics offers Next Generation Sequencing, Sanger Sequencing, MLPA/TP-PCR, and Prenatal Diagnosis.